Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 999 999.9999 KRW Market Closed
Market Cap: 71.2T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note
Section:
 

Profitability Summary

Samsung Biologics Co Ltd's profitability score is 62/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

62/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

62/100
Profitability
Score
62/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less
Revenue
+
3Y
+169%
5Y
+525%
10Y
-
Operating Income
+
3Y
+148%
5Y
+792%
10Y
-
Net Income
+
3Y
+167%
5Y
+360%
10Y
-

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Samsung Biologics Co Ltd

Revenue
4.9T KRW
Cost of Revenue
-2.3T KRW
Gross Profit
2.6T KRW
Operating Expenses
-1T KRW
Operating Income
1.6T KRW
Other Expenses
-305.9B KRW
Net Income
1.3T KRW

Margins Comparison
Samsung Biologics Co Ltd Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
53%
32%
26%
US
PerkinElmer Inc
LSE:0KHE
1T USD
56%
15%
10%
US
Thermo Fisher Scientific Inc
NYSE:TMO
150.9B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
134.5B USD
60%
22%
16%
CH
Lonza Group AG
SIX:LONN
39.1B CHF
37%
18%
10%
US
Agilent Technologies Inc
NYSE:A
31.2B USD
54%
24%
19%
CN
WuXi AppTec Co Ltd
SSE:603259
181.3B CNY
42%
27%
27%
US
IQVIA Holdings Inc
NYSE:IQV
24B USD
35%
15%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
23.3B USD
60%
29%
22%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR
44%
14%
7%
US
Waters Corp
NYSE:WAT
20.7B USD
59%
28%
22%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Samsung Biologics Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
12%
8%
12%
8%
US
PerkinElmer Inc
LSE:0KHE
1T USD
4%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
150.9B USD
14%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
134.5B USD
7%
5%
7%
6%
CH
Lonza Group AG
SIX:LONN
39.1B CHF
7%
4%
8%
6%
US
Agilent Technologies Inc
NYSE:A
31.2B USD
21%
11%
16%
14%
CN
WuXi AppTec Co Ltd
SSE:603259
181.3B CNY
20%
14%
17%
16%
US
IQVIA Holdings Inc
NYSE:IQV
24B USD
22%
5%
11%
8%
US
Mettler-Toledo International Inc
NYSE:MTD
23.3B USD
-499%
26%
52%
31%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR
5%
2%
5%
4%
US
Waters Corp
NYSE:WAT
20.7B USD
42%
14%
23%
17%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 256,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.